메뉴 건너뛰기




Volumn 105, Issue 1, 2014, Pages 45-52

Omalizumab in the treatment of chronic urticaria;Omalizumab en el tratamiento de la urticaria crónica

Author keywords

Anti immunoglobulin E; Chronic urticaria; Omalizumab; Treatment

Indexed keywords

OMALIZUMAB; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIIDIOTYPIC ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; MONOCLONAL ANTIBODY;

EID: 84893055718     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2013.06.002     Document Type: Short Survey
Times cited : (13)

References (47)
  • 6
    • 0028143496 scopus 로고
    • The binding site on human immunoglobulin e for its high affinity receptor
    • L. Presta, R. Shields, L. O'Connell, S. Lahr, J. Porter, and C. Gorman et al. The binding site on human immunoglobulin E for its high affinity receptor J Biol Chem 269 1994 26368 26373
    • (1994) J Biol Chem , vol.269 , pp. 26368-26373
    • Presta, L.1    Shields, R.2    O'Connell, L.3    Lahr, S.4    Porter, J.5    Gorman, C.6
  • 7
    • 33947420879 scopus 로고    scopus 로고
    • Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE omalizumab
    • I. Mirkina, T. Schweighoffer, and F. Kricek Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE omalizumab Inmmunol Lett 109 2007 120 128
    • (2007) Inmmunol Lett , vol.109 , pp. 120-128
    • Mirkina, I.1    Schweighoffer, T.2    Kricek, F.3
  • 8
    • 78651483333 scopus 로고    scopus 로고
    • Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab
    • M. Saavedra, and S. Sur Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab Clin Mol Allergy 9 2011 2
    • (2011) Clin Mol Allergy , vol.9 , pp. 2
    • Saavedra, M.1    Sur, S.2
  • 9
    • 0018193792 scopus 로고
    • IgE receptor on human basophils: Relationship to serum IgE concentration
    • F. Malveaux, M. Conroy, N. Adkinson, and L. Lichtenstein IgE receptor on human basophils: Relationship to serum IgE concentration J Clin Invest 62 1978 176 181
    • (1978) J Clin Invest , vol.62 , pp. 176-181
    • Malveaux, F.1    Conroy, M.2    Adkinson, N.3    Lichtenstein, L.4
  • 14
    • 0034881877 scopus 로고    scopus 로고
    • The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
    • M. Soler, J. Matz, R. Townley, R. Buhl, J. O'Brien, and H. Fox et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Eur Resp J 18 2001 254 261
    • (2001) Eur Resp J , vol.18 , pp. 254-261
    • Soler, M.1    Matz, J.2    Townley, R.3    Buhl, R.4    O'Brien, J.5    Fox, H.6
  • 15
    • 0141570710 scopus 로고    scopus 로고
    • Pharmacodynamics of omalizumab: Implications for optimized dosing strategies and clinical efficacy in the treatment of allergic asthma
    • G. Hochhaus, L. Brookman, H. Fox, C. Johnson, J. Matthews, and S. Ren et al. Pharmacodynamics of omalizumab: Implications for optimized dosing strategies and clinical efficacy in the treatment of allergic asthma Curr Med Res Opin 19 2003 491 498
    • (2003) Curr Med Res Opin , vol.19 , pp. 491-498
    • Hochhaus, G.1    Brookman, L.2    Fox, H.3    Johnson, C.4    Matthews, J.5    Ren, S.6
  • 16
    • 63449094824 scopus 로고    scopus 로고
    • Anti-IgE therapy
    • N.F.J. Adkinson, B.S. Bochner, W. Busse, S. Holgate, R.F.J. Lemanske, F.E.R. Simons, 7th ed. Mosby Elsevier Philadelphia
    • J. Stokes, and T.B. Casale Anti-IgE therapy N.F.J. Adkinson, B.S. Bochner, W. Busse, S. Holgate, R.F.J. Lemanske, F.E.R. Simons, Middleton's allergy principes and practice 7th ed. 2009 Mosby Elsevier Philadelphia 1679 1689
    • (2009) Middleton's Allergy Principes and Practice , pp. 1679-1689
    • Stokes, J.1    Casale, T.B.2
  • 17
    • 0043240429 scopus 로고    scopus 로고
    • Evaluation of long-term safety of the anti-IgE antibody, omalizumab in children with allergic asthma
    • W. Berger, N. Gupta, M. McAlary, and A. Fowler-Taylor Evaluation of long-term safety of the anti-IgE antibody, omalizumab in children with allergic asthma Ann Allergy Asthma Inmmunol 91 2003 182 188
    • (2003) Ann Allergy Asthma Inmmunol , vol.91 , pp. 182-188
    • Berger, W.1    Gupta, N.2    McAlary, M.3    Fowler-Taylor, A.4
  • 18
    • 36749096427 scopus 로고    scopus 로고
    • American Academy of Allergy, Asthma and Inmmunology/American College of Allergy, Asthma and Inmmunology Report on omalizumab-associated anaphilaxis
    • L. Cox, P. Lieberman, D. Wallace, F.E. Simons, I. Finegold, and T. Platts-Mills et al. American Academy of Allergy, Asthma and Inmmunology/American College of Allergy, Asthma and Inmmunology Report on omalizumab-associated anaphilaxis J Allergy Clin Inmmunol 120 2007 1373 1377
    • (2007) J Allergy Clin Inmmunol , vol.120 , pp. 1373-1377
    • Cox, L.1    Lieberman, P.2    Wallace, D.3    Simons, F.E.4    Finegold, I.5    Platts-Mills, T.6
  • 19
    • 79959821554 scopus 로고    scopus 로고
    • American Academy of Allergy, Asthma and Inmmunology/American College of Allergy, Asthma and Inmmunology. Omalizumab-Associated Anaphilaxis Joint Task Force follow-up report
    • L. Cox, P. Lieberman, D. Wallace, F.E. Simons, I. Finegold, and T. Platts-Mills et al. American Academy of Allergy, Asthma and Inmmunology/American College of Allergy, Asthma and Inmmunology. Omalizumab-Associated Anaphilaxis Joint Task Force follow-up report J Allergy Clin Inmmunol 128 2011 210 212
    • (2011) J Allergy Clin Inmmunol , vol.128 , pp. 210-212
    • Cox, L.1    Lieberman, P.2    Wallace, D.3    Simons, F.E.4    Finegold, I.5    Platts-Mills, T.6
  • 20
    • 26444439970 scopus 로고    scopus 로고
    • ®), a recombinant humanized monoclonal anti-IgE antibody
    • ®), a recombinant humanized monoclonal anti-IgE antibody Clin Rev Allergy Immunol 29 2005 31 48
    • (2005) Clin Rev Allergy Immunol , vol.29 , pp. 31-48
    • Deniz, Y.M.1    Gupta, N.2
  • 23
    • 33646947344 scopus 로고    scopus 로고
    • Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE
    • J.A. Boyce Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE J Allergy Clin Immunol 117 2006 1415 1418
    • (2006) J Allergy Clin Immunol , vol.117 , pp. 1415-1418
    • Boyce, J.A.1
  • 24
    • 34547944181 scopus 로고    scopus 로고
    • Effect of omalizumab on patients with chronic urticaria
    • S.L. Spector, and R.A. Tan Effect of omalizumab on patients with chronic urticaria Ann Allergy Asthma Immunol 99 2007 190 193
    • (2007) Ann Allergy Asthma Immunol , vol.99 , pp. 190-193
    • Spector, S.L.1    Tan, R.A.2
  • 25
    • 53749100152 scopus 로고    scopus 로고
    • Successful treatment of solar urticaria with anti-immunoglobulin e therapy
    • O. Güzelbey, E. Ardelean, M. Magerl, T. Zuberbier, M. Maurer, and M. Metz Successful treatment of solar urticaria with anti-immunoglobulin E therapy Allergy 63 2008 1563 1565
    • (2008) Allergy , vol.63 , pp. 1563-1565
    • Güzelbey, O.1    Ardelean, E.2    Magerl, M.3    Zuberbier, T.4    Maurer, M.5    Metz, M.6
  • 26
    • 80052872083 scopus 로고    scopus 로고
    • Omalizumab in treatment-resistant chronic spontaneous urticaria
    • K.V. Godse Omalizumab in treatment-resistant chronic spontaneous urticaria Indian J Dermatol 56 2011 444
    • (2011) Indian J Dermatol , vol.56 , pp. 444
    • Godse, K.V.1
  • 27
    • 37749011236 scopus 로고    scopus 로고
    • Successful treatment of cholinergic urticaria with anti-immunoglobulin e therapy
    • M. Metz, P. Bergmann, T. Zuberbier, and M. Maurer Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy Allergy 63 2008 247 249
    • (2008) Allergy , vol.63 , pp. 247-249
    • Metz, M.1    Bergmann, P.2    Zuberbier, T.3    Maurer, M.4
  • 28
    • 68249146545 scopus 로고    scopus 로고
    • A case of severe refractory chronic urticaria: A novel method for evaluation and treatment
    • H.F. Otto, and C.W. Calabria A case of severe refractory chronic urticaria: A novel method for evaluation and treatment Allergy Asthma Proc 30 2009 333 337
    • (2009) Allergy Asthma Proc , vol.30 , pp. 333-337
    • Otto, H.F.1    Calabria, C.W.2
  • 30
    • 77954941791 scopus 로고    scopus 로고
    • Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab
    • C. Vestergaard, and M. Deleuran Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab Acta Derm Venereol 90 2010 443 444
    • (2010) Acta Derm Venereol , vol.90 , pp. 443-444
    • Vestergaard, C.1    Deleuran, M.2
  • 31
    • 78649260196 scopus 로고    scopus 로고
    • Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin e therapy
    • K. Krause, E. Ardelean, B. Kessler, M. Magerl, M. Metz, and F. Siebenhaar et al. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy Allergy 65 2010 1494 1495
    • (2010) Allergy , vol.65 , pp. 1494-1495
    • Krause, K.1    Ardelean, E.2    Kessler, B.3    Magerl, M.4    Metz, M.5    Siebenhaar, F.6
  • 33
    • 76749153779 scopus 로고    scopus 로고
    • Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria
    • C. Romano, A. Sellitto, U. de Fanis, G. Esposito, P. Arbo, and R. Giunta et al. Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria Ann Allergy Asthma Immunol 104 2010 95 97
    • (2010) Ann Allergy Asthma Immunol , vol.104 , pp. 95-97
    • Romano, C.1    Sellitto, A.2    De Fanis, U.3    Esposito, G.4    Arbo, P.5    Giunta, R.6
  • 34
    • 77953111313 scopus 로고    scopus 로고
    • Effective treatment of refractory severe heat urticaria with omalizumab
    • U. Bullerkotte, D. Wieczorek, A. Kapp, and B. Wedi Effective treatment of refractory severe heat urticaria with omalizumab Allergy 65 2010 931 932
    • (2010) Allergy , vol.65 , pp. 931-932
    • Bullerkotte, U.1    Wieczorek, D.2    Kapp, A.3    Wedi, B.4
  • 35
    • 77951241500 scopus 로고    scopus 로고
    • Failure of omalizumab in cholinergic urticaria
    • R.A. Sabroe Failure of omalizumab in cholinergic urticaria Clin Exp Dermatol 35 2010 e127 e129
    • (2010) Clin Exp Dermatol , vol.35
    • Sabroe, R.A.1
  • 36
    • 72049102902 scopus 로고    scopus 로고
    • Efficacy of omalizumab in delayed pressure urticaria: A case report
    • C. Bindslev-Jensen, and P.S. Skov Efficacy of omalizumab in delayed pressure urticaria: A case report Allergy 65 2010 138 139
    • (2010) Allergy , vol.65 , pp. 138-139
    • Bindslev-Jensen, C.1    Skov, P.S.2
  • 37
    • 78649383197 scopus 로고    scopus 로고
    • Omalizumab therapy in three patients with chronic autoimmune urticaria
    • M. Al-Ahmad Omalizumab therapy in three patients with chronic autoimmune urticaria Ann Saudi Med 30 2010 478 481
    • (2010) Ann Saudi Med , vol.30 , pp. 478-481
    • Al-Ahmad, M.1
  • 38
    • 78651096597 scopus 로고    scopus 로고
    • Omalizumab - An effective and safe treatment of therapy-resistant chronic spontaneous urticaria
    • A. Groffik, H. Mitzel-Kaoukhov, M. Magerl, M. Maurer, and P. Staubach Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticaria Allergy 66 2011 303 305
    • (2011) Allergy , vol.66 , pp. 303-305
    • Groffik, A.1    Mitzel-Kaoukhov, H.2    Magerl, M.3    Maurer, M.4    Staubach, P.5
  • 41
    • 84859799340 scopus 로고    scopus 로고
    • Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey
    • S. Büyüköztürk, A. Gelincik, M. Demirtürk, E. Kocaturk, B. Colakoǧlu, and M. Dal Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey J Dermatol 39 2012 439 442
    • (2012) J Dermatol , vol.39 , pp. 439-442
    • Büyüköztürk, S.1    Gelincik, A.2    Demirtürk, M.3    Kocaturk, E.4    Colakoǧlu, B.5    Dal, M.6
  • 42
    • 84860776801 scopus 로고    scopus 로고
    • Omalizumab for chronic urticaria: A case series and overview of the literature
    • I. Ivyanskiy, C. Sand, and S.T. Francis Omalizumab for chronic urticaria: A case series and overview of the literature Case Rep Dermatol 4 2012 19 26
    • (2012) Case Rep Dermatol , vol.4 , pp. 19-26
    • Ivyanskiy, I.1    Sand, C.2    Francis, S.T.3
  • 45
    • 79959855552 scopus 로고    scopus 로고
    • Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
    • M. Maurer, S. Altrichter, T. Bieber, T. Biedermann, M. Bräutigam, and S. Seyfried et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase J Allergy Clin Inmmunol 128 2011 202 209
    • (2011) J Allergy Clin Inmmunol , vol.128 , pp. 202-209
    • Maurer, M.1    Altrichter, S.2    Bieber, T.3    Biedermann, T.4    Bräutigam, M.5    Seyfried, S.6
  • 46
    • 80052299857 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
    • S. Saini, K.E. Rosen, H.J. Hsieh, D.A. Wong, E. Conner, and A. Kaplan et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria J Allergy Clin Inmmunol 128 2011 567 573
    • (2011) J Allergy Clin Inmmunol , vol.128 , pp. 567-573
    • Saini, S.1    Rosen, K.E.2    Hsieh, H.J.3    Wong, D.A.4    Conner, E.5    Kaplan, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.